[126th JSS] Presenting Our Pancreatic Cancer Study
On April 25, during the 126th Annual Congress of the Japan Surgical Society held in Sapporo, Prof. Hidenori Takahashi, a co-investigator of the PC-CURE-1 study, presented a talk titled:
“Impact of Induction FOLFIRINOX versus Gemcitabine with Nab-Paclitaxel on Early Recurrence and Post-Recurrence Survival after Conversion Surgery for Unresectable Pancreatic Cancer.”
Report on the 13th International Conference of FACO in Shanghai
FACO’s pancreatic cancer study: Poster presentation at ESMO GI 2025
At the ESMO Gastrointestinal Cancers Congress 2025 (ESMO GI), held in Barcelona, Spain from 2 to 5 July 2025 one of the subgroup analyses from the FACO pancreatic cancer study PC-CURE-1 was presented as a poster.
The presentation, titled “Prognostic significance of CA19-9 before conversion surgery for patients with initially unresectable pancreatic cancer”, was delivered by Dr. Satoshi Kobayashi from Kanagawa Cancer Center.
The 13th International Conference of FACO-Shanghai
The 25th FACO Business Meeting
Prof. Koji Kono has been appointed as the new CEO of FACO
The 24th FACO Business Meeting
The 24th FACO Business Meeting was held in conjunction with the 12th FACO Conference, held in conjunction with the JSCO2024 Conference in Kobe.
The current FACO Chairman is Dr. Joon Oh Park from KSMO, Korea, and the Co-Chairs are Dr. Jin Li from CSCO, China, and Dr. Takayuki Yoshino from JSCO, Japan.
After the COVID-19 pandemic, the Chairs from the three countries gathered together for the first time in a long time, and it was decided that the FACO Academic Conference would be held in China, Korea, and Japan on a routine basis from next year for the next three years.
The 12th International Conference of FACO in conjunction with JSCO2024 Congress
Dr. Takayuki Yoshino, FACO Co-Chair from JSCO, also gave a talk.
Around 100 young researchers were dispatched to Kobe from the Chinese Society for Clinical Oncology (CSCO), a FACO member society from China, and they livened up the event.
Presentation at ACLC2024 Hong-Kong
PC-CURE-1 paper published : Hepato-Biliary-Pancreatic Sciences
Treatment choice for c-Stage III NSCLC survey enrollment starts
_%20-%20forms.office.com.png)
The fourth international collaborative project to be implemented by FACO is a survey on Treatment Choice for c-Stage III Non-Small Cell Lung Cancer, targeting specialists in medical oncologist, surgical oncologist, and radiational oncologist from Japan, Korea, and China. Dr. Hidehito Horinouchi (National Cancer Center Hospital) led a survey item input format using Microsoft Forms.
This survey asks researchers to indicate their clinical status, such as clinical stage and lymph node metastasis, and to answer their first-choice treatment.
There is a similar survey conducted by Dr. Horinouchi at a JCOG facility in Japan, but this survey is conducted in three East Asian countries and is conducted from an international perspective.
The deadline for case registration is May 13, 2024.
The 3rd FACO Lung Cancer Investigators Meeting (zoom)
The 2nd FACO Lung Cancer Academic Committee Meeting in Singapore
The 11th International Conference of FACO in conjunction with KSMO2023 Congress
The 1st FACO Lung Cancer Academic Committee Meeting
FACOでは、胃癌・乳癌・膵癌の試験を日中韓で行ってきましたが、次の国際試験の療育として、肺癌が候補となっています。
光冨徹哉先生が中心となり、日中韓の研究者たちが第1回会合をZoomにて開催しました。
FACO has conducted clinical trials for gastric, breast, and pancreatic cancer with the collaboration of China, Japan and Korea, and lung cancer is now a candidate for the next international trial.
Led by Dr. Tetsuya Mitsutomi, investigators from China, Japan, Korea held the first meeting at Zoom.
PC-CURE-1, presentation at the 109th General Meeting of the Japanese Society of Gastroenterology
.png)
Face-to-face Board Meeting for the new step for FACO
OLIGO-BC1 has been published at Breast Cancer
井本滋先生がPIをつとめる乳腺研究のOLIGO-BC1論文が「Breast Cancer」誌に掲載されました。
The academic paper of OLIGO-BC1 has been published at Breast Cancer.
The 10th International Conference in Shanghai + Virtual
第10回目となるFACOの学術集会は、COVIDの影響で残念ながらVirtual開催となりました（Virtualの基地：北京）。
乳癌・胃癌・大腸癌・肺癌・肝胆膵癌に関して、日中韓の研究者が最新情報を共有しました。
Unfortunately, the 10th International Conference of FACO was held virtually due to COVID-19 (base: Shanghai).
Researchers from Japan, China, and Korea shared the latest information on breast cancer, gastric cancer, colon cancer, lung cancer, and hepato-biliary-pancreatic cancer.
Results presentation to PC-CURE-1 joint research facility
.png)
(1) 開会のご挨拶 山上 裕機先生
(2) 成果報告 岡野 尚弘先生
(3) 質疑応答、discussion
(4) 閉会のご挨拶 古瀬 純司先生
The results of PC-CURE-1 study was presented via Zoom to the joint research facilities.